Save the date: Calliditas to host a Capital Markets Day in Stockholm, Sweden, on January 20, 2021
Calliditas Therapeutics AB (publ) (“Calliditas”) today announced that the company will host a Capital Markets Day in Stockholm, Sweden, on January 20, 2021 for investors, analysts and media.Presentations will be made by members of Calliditas’ management team as well as invited key opinion leaders. The program will include an overview of the company’s clinical development program, with a review of the recent successful topline data readout from the Phase 3 clinical study NefIgArd; the lead candidate drug Nefecon’s regulatory path towards potential market approval; an update on preparations